News
The 27-year-old son of Arnold Schwarzenegger and Maria Shriver spoke about his physical transformation at Beacher Vitality’s ...
The Japanese automaker announced broad layoffs last year and recently warned of weakened sales in the U.S. and China.
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.
The Dallas Cowboys will open the 2025 NFL season against the reigning Super Bowl champion Philadelphia Eagles. Will it be ...
NHK has learned that struggling Japanese automaker Nissan Motor plans to cut about 11,000 more jobs, bringing the firm's ...
Eli Lilly's tirzepatide leads to 50% more weight loss compared to Novo Nordisk's semaglutide in 72-week study.
My least favorite thing would be if people were to try to ‘Baby Reindeer’ it,” Dunham says of her upcoming Netflix show.
House Republicans propose $880 billion in Medicaid cuts to fund tax breaks. Learn how this could impact health care.
GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...
The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, compared the effectiveness of the two leading ...
Research into weight loss jabs Mounjaro and Wegovy has found both were effective for obese patients, but people tended to lose more weight using Mounjaro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results